fda glp-1 warning october 2025 30 telehealth companies received U.S. Food and Drug Administration letters for falsely marketing products online. said these companies claimed that their compounded products are similar to generic FDA-approved products FDA Requests Removal of Suicidal

Many people start with semaglutide and switch to tirzepatide if needed, which is a reasonable strategy

If Ozempic is one tactic youre employing on your journey, the Equinox GLP-1 protocol is the ideal complementary tactic one that will help you maximize your treatment's potential benefits

This unique amino acid dipeptide is used to support levels of carnosine in our muscles, which declines with age and those with chronic degenerative disorders

The fight that Eli Lilly and Novo Nordisk are taking to the compounding pharmacies, which has moved into courts with lawsuits against telehealth companies, will produce winners and losers with huge amounts of money at stake

No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared either component peptide, or the blend formulation, as a drug for human or veterinary use

2012;7:e50117